New radiation delivery system gives new hope to colorectal cancer patientsNovember 14th, 2007 - 1:58 am ICT by admin
Colorectal cancer specialists Dr. John Abraham and Dr. Stephen Meltzer say that the new radiation delivery system has been found to have the potential to specifically target colon cancer cells in laboratory studies with normal and cancer cells.
The researchers say that the delivery system’s molecules are so small that the kidneys may easily filter out their left over.
Considering that small molecules generally make better treatment packages, the researchers designed small bits of protein as the foundation for their drugs.
Whereas, antibodies used to deliver radiation or chemicals can be over one thousand amino acids long, the bits of proteins designed by Hopkins scientists are only 10 amino acids long.
Dr. Abraham revealed that his team attached radioactive phosphorous, P32, as a test of how well their peptides worked.
“To our surprise, our first tests showed that cells were ingesting these molecules, thus transferring the radiation inside and killing them by breaking up their DNA and proteins,” he said.
He further revealed that P32 gave off high energy that could penetrate through 5 millimetres of human tissue, a reason behind it being a good candidate to tackle colon cancer. He corroborated this suggestion with the fact that colon cancer cells often form large, thick tumours into which drugs may not penetrate very well.
Dr. Abraham also said that P32-labeled peptides might be helpful in finding small metastases or recurrences of colon tumours, while they are still small enough to treat.
He also revealed that tests with a variety of P32-peptides on 18 normal and cancerous human cell samples showed that the most potent peptide, MA5, could bind to adenocarcinoma cells that make up 95 percent of all colon cancers 150 times more strongly than other cell types. It could be transferred inside cells within two hours, the researcher added.
The study has been reported in online in PLoS One. (ANI)
- Peptide to enhance cancer drug effectiveness - Apr 09, 2010
- Trio of drugs may help fight 'triple negative' breast cancer - Dec 11, 2010
- Nanotechnology could help smuggle drugs into the gut - Nov 05, 2010
- Peptide that triggers diabetes in mice identified - Jun 17, 2010
- Now, a tiny white bread mint like capsule to track cancer in the body - Mar 16, 2011
- Scientists get glimpse of how 'code' of life may have emerged - Mar 24, 2011
- Silica cages help anti-cancer antibodies prevent tumour growth in mice - May 22, 2010
- Slowing down prostate cancer by starving its cells - Nov 03, 2011
- Now, 'Trojan Horse' delivery system to attack cancer cells from inside - Jul 28, 2010
- How some people control HIV infection naturally - Nov 05, 2010
- Intestinal stem cells offer clues to colon cancer origin and relapse - Mar 18, 2011
- Nanosponge drug treatment 3-5 times more effective than jabs - Jun 03, 2010
- 'On-off' switch for key 'factor' in heart disease, cancer identified - Apr 07, 2011
- Now, a method to predict nanoparticle interaction with human body - Aug 16, 2010
- Raman effect makes cancer detection possible - Apr 21, 2011
Tags: adenocarcinoma, amino acids, bind, cancer specialists, colon cancer cells, colon cancers, colon tumours, colorectal cancer patients, delivery system, dr abraham, drugs, hopkins scientists, john abraham, molecules, p32, peptides, proteins, radiation, target